Deng Xinna, Wu Haijiang, Gao Fei, Su Ye, Li Qingxia, Liu Shuzhen, Cai Jianhui
Department of Oncology & Immunotherapy, Hebei General Hospital, Shijiazhuang, China.
Department of Pathology, Hebei Medical University, Shijiazhuang, China.
Int J Clin Oncol. 2017 Aug;22(4):641-650. doi: 10.1007/s10147-017-1155-5. Epub 2017 Jun 29.
Brachytherapy is an important radio-therapeutic modality for a variety of malignancies, including prostate cancer, cervix cancer, breast cancer, vagina cancer, endometrium cancer, head and neck cancer, and many more. This technique has been shown to be an effective and safe non-pharmaceutical treatment with fewer serious complications and better outcome than other treatments for breast cancer. Every year, hundreds of thousands of patients around the world benefit from brachytherapy, which reliably delivers a relatively higher radiation dose to the intended target. However, the follow-up time, patient eligibility criteria, treatment strategy, and radiation doses used in published studies are somewhat inconsistent, making it difficult to strictly compare and evaluate the performance of the treatment. More rigorous studies are required to confirm the safety of this technique and to make outcome data more comparable. In this review, we focus on recent advances in breast brachytherapy techniques and provide an overview of outcomes, cosmetic outcome, toxicity, complications, and limitations of brachytherapy for the treatment of breast cancer. We also summarize the clinical outcomes and toxicity results in patients receiving or not receiving brachytherapy.
近距离放射治疗是一种针对多种恶性肿瘤的重要放射治疗方式,包括前列腺癌、宫颈癌、乳腺癌、阴道癌、子宫内膜癌、头颈癌等等。该技术已被证明是一种有效且安全的非药物治疗方法,与其他乳腺癌治疗方法相比,严重并发症更少,治疗效果更好。每年,全球成千上万的患者受益于近距离放射治疗,它能可靠地向预定靶区输送相对较高的辐射剂量。然而,已发表研究中的随访时间、患者入选标准、治疗策略以及使用的辐射剂量存在一定的不一致性,这使得难以严格比较和评估该治疗方法的性能。需要更严谨的研究来证实该技术的安全性,并使结果数据更具可比性。在本综述中,我们聚焦于乳腺近距离放射治疗技术的最新进展,并概述近距离放射治疗在治疗乳腺癌方面的疗效、美容效果、毒性、并发症及局限性。我们还总结了接受或未接受近距离放射治疗患者的临床疗效和毒性结果。